Etiocholanolone: Difference between revisions
Content deleted Content added
m removing old orphan tags, removed orphan tag using AWB |
No edit summary |
||
(64 intermediate revisions by 30 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Unreferenced stub|auto=yes|date=December 2009}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| verifiedrevid = 413760240 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| alt = Skeletal formula of etiocholanolone |
|||
⚫ | |||
| image2 = Etiocholanolone 3D ball.png |
|||
⚫ | |||
| alt2 = Ball-and-stick model of the etiocholanolone molecule |
|||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| tradename = |
|||
| molecular_weight = 290.445 g/mol |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
| pregnancy_US = <!-- A / B / C / D / X --> |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> |
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> |
||
| legal_UK = <!-- GSL / P / POM / CD --> |
| legal_UK = <!-- GSL / P / POM / CD --> |
||
| legal_US = <!-- OTC / Rx-only --> |
| legal_US = <!-- OTC / Rx-only --> |
||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
|||
⚫ | |||
| UNII_Ref = {{fdacite|changed|FDA}} |
|||
| UNII = 97CGB1M48I |
|||
| ChEBI_Ref = {{ebicite|changed|EBI}} |
|||
| ChEBI = 28195 |
|||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 85799 |
|||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 5669 |
|||
<!--Chemical data--> |
|||
⚫ | |||
⚫ | |||
| smiles = [H][C@]12CC[C@@]3([H])[C@]4([H])CCC(=O)[C@@]4(C)CC[C@]3([H])[C@@]1(C)CC[C@@H](O)C2 |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14+,15+,16+,18+,19+/m1/s1 |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = QGXBDMJGAMFCBF-BNSUEQOYSA-N |
|||
}} |
}} |
||
'''Etiocholanolone''', also known as '''5β-androsterone''', as well as '''3α-hydroxy-5β-androstan-17-one''' or '''etiocholan-3α-ol-17-one''', is an [[etiocholane]] (5β-androstane) [[steroid]] as well as an [[endogenous]] [[17-ketosteroid]] that is produced from the [[metabolism]] of [[testosterone]]. It causes [[fever]], [[immunostimulant|immunostimulation]], and [[leukocytosis]], and is used to evaluate [[adrenal cortex]] function, [[bone marrow]] performance, and in [[neoplasm|neoplastic disease]] to stimulate the [[immune system]]. Etiocholanolone is also known to be an [[inhibitory postsynaptic potential|inhibitory]] [[androstane]] [[neurosteroid]],<ref name="pmid21094889">{{cite book | author = Reddy DS | title = Sex Differences in the Human Brain, their Underpinnings and Implications | chapter = Neurosteroids | journal = Prog. Brain Res. | volume = 186 | pages = 113–37 | year = 2010 | pmid = 21094889 | pmc = 3139029 | doi = 10.1016/B978-0-444-53630-3.00008-7 | series = Progress in Brain Research | isbn = 9780444536303 }}</ref> acting as a [[positive allosteric modulator]] of the [[GABAA receptor|GABA<sub>A</sub> receptor]],<ref name="pmid17341652">{{cite journal | vauthors = Li P, Bracamontes J, Katona BW, Covey DF, Steinbach JH, Akk G | title = Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor | journal = Molecular Pharmacology | volume = 71 | issue = 6 | pages = 1582–1590 | date = June 2007 | pmid = 17341652 | pmc = 3788649 | doi = 10.1124/mol.106.033407 | s2cid = 44286086 }}</ref> and possesses [[anticonvulsant]] effects.<ref name="pmid15946323">{{cite journal | vauthors = Kaminski RM, Marini H, Kim WJ, Rogawski MA | title = Anticonvulsant activity of androsterone and etiocholanolone | journal = Epilepsia | volume = 46 | issue = 6 | pages = 819–827 | date = June 2005 | pmid = 15946323 | pmc = 1181535 | doi = 10.1111/j.1528-1167.2005.00705.x }}</ref> The unnatural enantiomer of etiocholanolone is more potent as a positive allosteric modulator of GABA<sub>A</sub> receptors and as an anticonvulsant than the natural form.<ref>{{cite journal | vauthors = Zolkowska D, Dhir A, Krishnan K, Covey DF, Rogawski MA | title = Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms | journal = Psychopharmacology | volume = 231 | issue = 17 | pages = 3325–3332 | date = September 2014 | pmid = 24705905 | pmc = 4134984 | doi = 10.1007/s00213-014-3546-x }}</ref> |
|||
'''Etiocholanolone''' (or '''aetiocholanolone''') is a metabolite of [[testosterone]]. Classified a [[ketosteroid]], it causes [[fever]], [[immunostimulation]] and [[leukocytosis]]; is used to evaluate [[adrenal cortex]] function, bone marrow performance and in [[neoplastic]] disease for immunostimulation. |
|||
Etiocholanolone has been studied as a [[pyrogenic]] steroid in the so-called steroid fever (or etiocholanolone fever),<ref>{{cite journal | vauthors = Heckel GP |title= Steroid fever |journal=The Lancet |date=April 1963 |volume=281 |issue=7285 |pages=835–836 |doi=10.1016/S0140-6736(63)91549-6}}</ref><ref>{{cite journal | vauthors = Kappas A, Palmer RH | title = Novel biological properties of steroid metabolites; fever-production in man | journal = Journal of the Reticuloendothelial Society | volume = 4 | issue = 4 | pages = 231–236 | date = July 1967 | pmid = 6056839 }}</ref> a condition similar to [[Familial Mediterranean fever|familial mediterranean fever]] (FMF). Etiocholanolone (like [[pregnanolone]]) activates the [[pyrin]] [[inflammasome]].<ref>{{cite journal | vauthors = Magnotti F, Chirita D, Dalmon S, Martin A, Bronnec P, Sousa J, Helynck O, Lee W, Kastner DL, Chae JJ, McDermott MF, Belot A, Popoff M, Sève P, Georgin-Lavialle S, Munier-Lehmann H, Tran TA, De Langhe E, Wouters C, Jamilloux Y, Henry T | display-authors = 6 | title = Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanism | journal = Cell Reports | volume = 41 | issue = 2 | pages = 111472 | date = October 2022 | pmid = 36223753 | doi = 10.1016/j.celrep.2022.111472|biorxiv=10.1101/2021.10.29.466454 | pmc = 9626387 | s2cid = 240345817 | doi-access=free }}</ref> It is not known whether these endogenous [[Steroid|steroids]] play a role in triggering [[Familial Mediterranean fever|FMF]] flares but they may make a link between [[Stress (biology)|stress]], [[menstrual cycle]] and disease flares.<ref>{{cite journal | vauthors = Karadag O, Tufan A, Yazisiz V, Ureten K, Yilmaz S, Cinar M, Akdogan A, Erdem H, Ozturk MA, Pay S, Dinc A | display-authors = 6 | title = The factors considered as trigger for the attacks in patients with familial Mediterranean fever | journal = Rheumatology International | volume = 33 | issue = 4 | pages = 893–897 | date = April 2013 | pmid = 22814791 | doi = 10.1007/s00296-012-2453-x | s2cid = 25599588 }}</ref><ref>{{cite journal | vauthors = Akar S, Soyturk M, Onen F, Tunca M | title = The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients | journal = Rheumatology International | volume = 26 | issue = 7 | pages = 676–679 | date = May 2006 | pmid = 16184383 | doi = 10.1007/s00296-005-0041-z | s2cid = 1617088 }}</ref> |
|||
Etiocholanolone is produced from [[5β-dihydrotestosterone]], with [[3α,5β-androstanediol]] as an [[metabolic intermediate|intermediate]]. |
|||
==Chemistry== |
|||
{{See also|List of neurosteroids}} |
|||
== See also == |
|||
* [[Androsterone]] |
|||
* [[Epiandrosterone]] |
|||
* [[Epietiocholanolone]] |
|||
* [[Etiocholanolone glucuronide]] |
|||
== References == |
|||
{{Reflist}} |
|||
{{Steroid hormones}} |
|||
⚫ | |||
{{GABAAR PAMs}} |
|||
⚫ | |||
[[Category:Neurosteroids]] |
|||
[[Category:GABAA receptor positive allosteric modulators]] |
|||
[[Category:Human metabolites]] |
|||
[[Category:World Anti-Doping Agency prohibited substances]] |
|||
{{ |
{{steroid-stub}} |